<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00862914</url>
  </required_header>
  <id_info>
    <org_study_id>006</org_study_id>
    <nct_id>NCT00862914</nct_id>
  </id_info>
  <brief_title>Immunohistochemical Expression Patterns of microRNA Processing Enzyme Dicer in Cutaneous Malignant Melanoma, Benign and Dysplastic Melanocytic Naevi</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ruhr University of Bochum</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ruhr University of Bochum</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      MicroRNAs (miRNAs) are very small endogenous RNA molecules about 22-25 nucleotides in length,
      capable of post-transcriptional gene regulation. miRNAs bind to their target messenger RNAs
      (mRNAs), leading to cleavage or suppression of target mRNA translation based on the degree of
      complementarity. miRNAs have recently been shown to play pivotal roles in diverse
      developmental and cellular processes and linked to a variety of skin diseases and cancers. In
      the present study the researchers investigate the immunohistochemical distribution of Dicer
      in benign and dysplastic melanocytic naevi as well as in cutaneous malignant melanoma
      compared to intraindividual healthy control.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>July 2008</start_date>
  <completion_date type="Actual">March 2009</completion_date>
  <primary_completion_date type="Actual">February 2009</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Actual">30</enrollment>
  <condition>Naevi</condition>
  <condition>Malignant Melanoma</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <description>benign melanocytic naevi</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <description>dysplastic melanocytic naevi</description>
  </arm_group>
  <arm_group>
    <arm_group_label>3</arm_group_label>
    <description>cutaneous malignant melanoma</description>
  </arm_group>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Paraffin embedded melanocytic skin lesion
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        dermatologic primary care clinic
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with benign melanocytic naevi, dysplastic melanocytic naevi and cutaneous
             malignant melanoma.

        Exclusion Criteria:

          -  Patients under 18 years of age

          -  Patients with other forms of cancer in previous medical history

          -  Pregnancy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Prof. Dr. Peter Altmeyer</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Dermatology and Allergology, Ruhr-University Bochum</affiliation>
  </overall_official>
  <overall_official>
    <last_name>PD Dr. Falk G. Bechara</last_name>
    <role>Study Director</role>
    <affiliation>Department of Dermatology and Allergology, Ruhr-University Bochum</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Department of Dermatology and Allergology, Ruhr-University Bochum</name>
      <address>
        <city>Bochum</city>
        <state>NRW</state>
        <zip>44791</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <results_reference>
    <citation>Sand M, Gambichler T, Sand D, Altmeyer P, Stuecker M, Bechara FG. Immunohistochemical expression patterns of the microRNA-processing enzyme Dicer in cutaneous malignant melanomas, benign melanocytic nevi and dysplastic melanocytic nevi. Eur J Dermatol. 2011 Jan-Feb;21(1):18-21. doi: 10.1684/ejd.2011.1210.</citation>
    <PMID>21262599</PMID>
  </results_reference>
  <verification_date>October 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 16, 2009</study_first_submitted>
  <study_first_submitted_qc>March 16, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 17, 2009</study_first_posted>
  <last_update_submitted>October 15, 2012</last_update_submitted>
  <last_update_submitted_qc>October 15, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 16, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Ruhr University of Bochum</investigator_affiliation>
    <investigator_full_name>Michael Sand</investigator_full_name>
    <investigator_title>Dr.</investigator_title>
  </responsible_party>
  <keyword>Skin</keyword>
  <keyword>MicroRNA</keyword>
  <keyword>miRNA</keyword>
  <keyword>Dicer</keyword>
  <keyword>Malignant Melanoma</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Melanoma</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

